Neuroblastoma trials in Greece

2 of 2 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  Where

  Athens

  Age

  6 months to 25 years

  People

  90 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06395103 · EU 2023-507178-41-00
• Phase 3Taking people
  High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

  Where

  Athens, Heraklion, Marousi, Thessaloniki

  Age

  Up to 21 years

  People

  800 worldwide

  Run by

  Gustave Roussy, Cancer Campus, Grand Paris

  See details and how to joinNCT04221035 · EU 2024-514917-36-00